J. Mark FitzGerald - Concepedia

Author

J. Mark FitzGerald

Also Known As

Gail M. Gauvreau, J FITZGERALD, J M FitzGerald, J M. FitzGerald, J Mark FitzGerald, J Mark Fitzgerald, J. FitzGerald, J. Fitzgerald, J. M. FitzGerald, J. M. Fitzgerald

138

Publications

8.7K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia Vancouver General Hospital McMaster University Université Laval Institut universitaire de cardiologie et de pneumologie de Québec

About

J. Mark FitzGerald is an author at University of British Columbia specializing in medicine, asthma, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	3.9K
2	Allergy	13	15	2.4K
3	Public Health	5	5	350
4	Education	1	1	13
5	Social Sciences	1	1	10

J. Mark FitzGerald

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair, The Lancet AsthmaRheumatologyPlacebo-controlled Phase 3ImmunologyClinical Trials	2016	1.3K
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial Eugene R. Bleecker, J. Mark FitzGerald, Pascal Chanez, The Lancet AsthmaAllergyPlacebo-controlled Phase 3Clinical TherapeuticPharmacology	2016	1.3K
Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies J. Mark FitzGerald, Eugene R. Bleecker, Andrew Menzies‐Gow, The Lancet Respiratory Medicine AsthmaRheumatologyAllergyImmunologyCalima Studies	2017	309
Antibiotic Use in Children Is Associated With Increased Risk of Asthma Fawziah Marra, Carlo A. Marra, Kathryn Richardson, PEDIATRICS	2009	281
Bronchial Thermoplasty for Asthma Gerard Cox, John D. Miller, Annette McWilliams, American Journal of Respiratory and Critical Care Medicine	2006	278
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma Eugene R. Bleecker, Michael E. Wechsler, J. Mark FitzGerald, European Respiratory Journal	2018	237
Asthma Control in Canada Remains Suboptimal: The Reality of Asthma Control (TRAC) Study J. Mark FitzGerald, Louis‐Philippe Boulet, Andrew McIvor, Canadian Respiratory Journal	2006	234
Canadian Thoracic Society Asthma Management Continuum – 2010 Consensus Summary for Children Six Years of Age and Over, and Adults M. Diane Lougheed, Catherine Lemière, Sharon Dell, Canadian Respiratory Journal	2010	202
Canadian Asthma Consensus Conference Summary of Recommendations Pierre Ernst, J. Mark FitzGerald, Sheldon Spier Canadian Respiratory Journal AsthmaFamily MedicinePulmonary CareCritical ReviewAllergy Medicine	1996	190
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study Sandhya Khurana, Guy Brusselle, Elisabeth H. Bel, Clinical Therapeutics	2019	161

Page 1